Mountain Mahogany (Cercocarpus spp.): A Comprehensive Reference
Identity and Botanical Classification
Taxonomic Position and Species
Cercocarpus, commonly known as mountain mahogany, is a small genus of at least nine species of nitrogen-fixing flowering plants in the rose family, Rosaceae. It is not a true mahogany: that distinction belongs to trees in the Meliaceae, the mahogany family. This shrubby, slow-growing tree belongs instead in the Rosaceae, or rose family; the common name derives from the dense, heavy wood. The genus has been placed in the subfamily Rosoideae, but is now placed in subfamily Dryadoideae.
The genus Cercocarpus was established in 1824 by Carl Sigismund Kunth in Nova Genera et Species Plantarum. The name derives from the Greek words kerkos (tail) and karpos (fruit), alluding to the distinctive plumed, tail-like styles of the achene fruits.
The three most medicinally and ethnobotanically significant species are:
- Cercocarpus ledifolius Nutt. — curl-leaf mountain mahogany. The most widely documented species for medicinal use. Evergreen, found throughout the Great Basin and western mountain ranges.
- Cercocarpus montanus Raf. — alderleaf or true mountain mahogany. Deciduous to evergreen, distributed from the Rockies to the Great Plains and northern Mexico. Also known by common names including silverleaf mountain mahogany and hardtack.
- Cercocarpus betuloides Nutt. — birch-leaf mountain mahogany. Predominant in California chaparral and adjacent ranges.
Other recognized species include C. breviflorus A.Gray (hairy mountain mahogany), C. intricatus S.Watson (littleleaf mountain mahogany), and C. douglasii Rydb. There are approximately 28 species of Cercocarpus native to the western United States and northern Mexico, where they grow in chaparral and semidesert habitats and climates, often at high altitudes.
Morphology and Identifying Features
Cercocarpus members are deciduous shrubs or small trees, typically reaching heights of 3–6 m (9–18 ft) tall, but exceptionally up to 13 m (40 ft) high. C. ledifolius is a large, densely branching tree which can reach heights of 11 metres (36 feet), although it is not uncommon to find the adult plant as a shrub as short as 1 m. Its leathery, sticky, dark green leaves are up to 4 centimetres long and lance-shaped, and the edges may curl under. The genus is characterized by simple, persistent or deciduous leaves (0.3–7.8 cm long), apetalous flowers (6–15 mm in diameter) with numerous stamens (10–61), and distinctive fruits consisting of achenes topped by a persistent, plumose style that aids in wind dispersal.
C. ledifolius is slow-growing, sometimes taking up to a century to reach full height. The oldest specimens are thought to be around 1,350 years old. C. montanus is an evergreen shrub of sparse habit up to 10 or 12 ft high, with thick, persistent bark.
Natural Distribution and Ecology
Mountain mahoganies are native to the western United States and northern Mexico, where they grow in chaparral and semidesert habitats and climates, often at high altitudes. Several are found in the California chaparral and woodlands ecoregion. C. ledifolius can be found at elevations ranging from 600 to 3,000 m (2,000 to 9,800 ft). It prefers shallow, well-drained soils with a sandy or grainy consistency, and is generally found in areas which receive only 15–26 cm (6–10 in) annual precipitation. This makes it common on low mountains and slopes, where it grows in scattered groves among other drought-resistant species such as pinyon pines, junipers and sagebrush.
C. montanus is a native shrub or small tree in the rose family found in the western USA and northern Mexico along rocky hillsides, cliffs, open woods and mesas. It is found in the foothills of the Rocky Mountains and the Great Plains at 5,000–8,000 feet elevation. It is deciduous to evergreen depending on where it is growing.
A distinctive ecological feature of Cercocarpus is its nitrogen-fixing capacity. These actinorhizal plants form symbiotic relationships with Frankia bacteria in root nodules, enabling them to thrive in nutrient-poor soils by fixing atmospheric nitrogen. Soils supporting C. ledifolius in association with Pinus flexilis were found to have higher percentages of total nitrogen than soils beneath similar stands lacking Cercocarpus. An excavated C. ledifolius shrub was found to be nodulated and these nodules were found to be capable of fixing nitrogen.
Common Forms, Preparations, and Parts Used
The plant parts most commonly used medicinally across traditions include the bark (especially inner bark), roots, leaves, and occasionally the wood itself. Traditional preparations documented in ethnobotanical records include:
- Decoctions of the bark or roots, prepared by boiling in water
- Infusions (teas), particularly of the leaves
- Cold infusions of the leaves or whole plant
- Poultices of powdered or fresh plant material, applied topically
- Powdered charcoal from burned wood, applied directly to skin
- Exudate dried and ground into powder for topical application
The scraped bark also makes a flavourful addition to a brew of Mormon tea (Ephedra spp.). A red dye is obtained from the inner bark. As a dietary supplement in contemporary commerce, mountain mahogany is sold primarily as a dried bark powder, liquid extract, or as an ingredient in multi-botanical formulas.
Traditional and Historical Use
Native American Ethnobotany
Mountain mahogany was employed medicinally by a number of native North American Indian tribes who used it to treat a variety of complaints. The plant's medicinal use among Indigenous peoples of the American West is among the most extensively documented aspects of its traditional history, recorded across many linguistic and cultural groups including the Paiute, Shoshone, Navajo, Gosiute, Kawaiisu, Tewa, Apache, Keres (Western), Isleta, Jemez, Hopi, and various California Indigenous nations.
Respiratory and Cold-Related Uses
A decoction has been used in the treatment of coughs and colds, pneumonia, spitting up of blood, stomach aches, diarrhoea (including for children), tuberculosis and venereal disease. Native people used the tree medicinally, especially the bark, in the treatment of various ills. Part of the bark is boiled with Ephedra to give the tea a pleasing taste; Cercocarpus bark tea is also used for treating colds. Mountain mahogany was used medicinally by Native American tribes such as the Paiute and the Shoshone to treat colds, burns, heart troubles and diarrhea.
Gastrointestinal Uses
An infusion of the leaves has been used as a general strengthener to the system. The roots and the bark have been used in the treatment of stomach complaints. The Navajo used bark tea for stomach disorders. The Tewa took a cold infusion of the plant or leaves as a laxative. The Western Keres used an infusion of leaves as a strengthener.
Wound Healing, Dermatological, and Topical Uses
A poultice of the green powdered wood has been applied to sores, cuts, wounds and burns. It has also been sprinkled on syphilitic sores. An exudation from the plant has been dried, ground into a powder and applied to the ear to treat earaches. Other groups used poultices of the leaves for skin problems and bruises. The White Mountain Apache burned wood, powdered the charcoal, and applied it to burns.
Cardiovascular and Haemostatic Uses
Ethnobotanical records describe the bark as possessing antihaemorrhagic, cardiac, stomachic, and tonic properties. Mountain mahogany was used medicinally by Native American tribes such as the Paiute and the Shoshone to treat colds, burns, heart troubles and diarrhea. The classification of the bark as "cardiac" in traditional use refers to the use of bark preparations in situations involving heart troubles or circulatory weakness, as recorded in aggregated ethnobotanical databases.
Venereal Disease and Reproductive Uses
Cercocarpus ledifolius (mountain mahogany, Rosaceae) is used by the Kawaiisu, Paiute and Shoshone as a treatment for gonorrhea or syphilis internally or externally.
Tribal-Specific Documented Uses (C. montanus)
Based on the Native American Ethnobotany Database (University of Michigan, Dearborn), the following specific tribal uses have been recorded for C. montanus:
- Isleta: Root bark used with alder root bark and wild plum root bark to make a red dye for buckskin.
- Jemez: Bark boiled together with alder bark and birch bark and used as red dye to paint moccasins.
- Keres (Western): Infusion of leaves used as a strengthener.
- Tewa: Cold infusion of plant or leaves taken as a laxative.
- White Mountain Apache: Wood burned, the charcoal powdered and applied to burns.
- Hopi: Wood used to make pahos (prayersticks).
- Navajo: Wood used to make the handle of the weaving distaff, dice and the sweathouse for ceremonies.
Non-Medicinal Traditional Uses
The Shoshone, Paiute, Bannock, and other Great Basin tribes used the dense, hard wood for tool handles, digging sticks, bows, and saddle frames. Native Americans, due to its strength and durability, used it for small, handmade items such as bows, spearheads, and special sticks for extricating subterranean foods. A reddish-brown dye can be made from the roots and bark, used for dyeing baskets and leather. The hard wood is also excellent fuel, and was used to smelt ore during the Comstock era.
Key Constituents and Phytochemistry
Overview of Chemical Profile
Dedicated phytochemical research specifically on Cercocarpus species published in peer-reviewed literature is extremely limited, and no comprehensive published analysis of isolated active compounds from these species was retrievable from PubMed or other primary scientific databases at the time of writing. The following is derived from general botanical chemistry knowledge of the genus based on its family membership, traditional use context, and what has been recorded in botanical reference literature.
Members of the Rosaceae family — and especially genera in the subfamily Dryadoideae — are characteristically rich in polyphenolic compounds. Based on the plant's traditional uses (astringent, antihaemorrhagic, antimicrobial, stomachic) and its botanical position, the following compound classes are plausibly present and have been noted in general ethnobotanical literature:
- Condensed tannins (proanthocyanidins): Consistent with the bark's noted astringency and haemostatic properties, and typical of bark-rich Rosaceae members.
- Flavonoids: Including flavonols and flavan-3-ols, common throughout Rosaceae.
- Phenolic acids: Gallic acid and related compounds consistent with the family's chemistry.
- Terpenoids: Commonly found in bark resins of woody Rosaceae.
Preliminary laboratory studies suggest that extracts from Cercocarpus species may help reduce oxidative stress and modulate inflammatory pathways, supporting the traditional uses for general wellness. However, these reports are not accompanied by peer-reviewed primary data in indexed journals and must be interpreted as preliminary characterizations rather than established findings.
It is important to note that no peer-reviewed isolation studies, chromatographic analyses (HPLC, GC-MS, LC-MS), or pharmacognostic monographs specific to Cercocarpus medicinal use were identified during research for this article. This represents a significant gap in the published scientific literature and means that specific active compound identification, quantification, and standardization are not yet established.
Nitrogen-Fixing Root Nodule Chemistry
A biochemically notable feature of the genus is its root chemistry. Some members of this genus have a symbiotic relationship with certain soil micro-organisms; these form nodules on the roots of the plants and fix atmospheric nitrogen. Some of this nitrogen is utilized by the growing plant but some can also be used by other plants growing nearby. Subfamily Dryadoideae fruits are achenes with hairy styles, and includes five genera (Dryas, Cercocarpus, Chamaebatia, Cowania, and Purshia), most species of which form root nodules which host nitrogen-fixing bacteria from the genus Frankia. The Frankia association enriches surrounding soils with available nitrogen and may influence the secondary metabolite profile of the plant, though this relationship has not been studied from a phytochemical standpoint in Cercocarpus.
Scientific Evidence by Area of Use
General Research Status
Mountain mahogany was employed medicinally by a number of native North American Indian tribes who used it to treat a variety of complaints. It is virtually not used in modern herbalism. This statement from botanical reference literature accurately summarizes the state of clinical and scientific evidence: there are no published randomized controlled trials, systematic reviews, or formal clinical studies evaluating the safety or efficacy of Cercocarpus preparations in humans in indexed scientific databases. The following section evaluates available evidence by domain.
Antioxidant Activity
Preliminary laboratory studies suggest that extracts from Cercocarpus species may help reduce oxidative stress and modulate inflammatory pathways, supporting the traditional uses for general wellness. No peer-reviewed publications describing specific in vitro antioxidant assay results (e.g., DPPH, ABTS, FRAP values) for Cercocarpus bark or leaf extracts were identified in PubMed, PMC, or comparable databases. Evidence at this stage is confined to general claims derived from the genus's membership in a polyphenol-rich plant family and informal ethnobotanical databases.
Evidence strength: Not yet established in peer-reviewed literature. No human or in vitro data retrievable from indexed sources.
Antimicrobial Activity
Traditional preparations of Cercocarpus bark decoctions were used in the treatment of tuberculosis and venereal disease. The use of bark preparations against infections caused by Mycobacterium tuberculosis and sexually transmitted pathogens — uses common to many tannin-rich barks — is ethnobotanically consistent. However, no published microbiological or clinical studies examining the antimicrobial activity of Cercocarpus extracts against specific pathogens were identified in indexed scientific databases.
Evidence strength: Traditional use documented; no peer-reviewed in vitro or clinical evidence identified.
Gastrointestinal Function
Multiple tribes documented the use of Cercocarpus bark, root, and leaf infusions for diarrhea, stomach aches, and as a laxative. An infusion of the leaves has been used as a general strengthener to the system. The roots and the bark have been used in the treatment of stomach complaints. The astringent properties attributed to tannin-rich bark preparations are pharmacologically consistent with antidiarrheal folk use — tannins are known to precipitate proteins, reduce intestinal permeability, and inhibit secretion — but no clinical or laboratory studies specifically evaluating Cercocarpus preparations for gastrointestinal endpoints have been published in peer-reviewed literature.
Evidence strength: Traditional use well-documented across multiple tribes; mechanistic plausibility exists based on tannin content, but no clinical or in vitro studies confirmed.
Wound Healing and Haemostasis
A poultice of the green powdered wood has been applied to sores, cuts, wounds and burns. The plant's classification as antihaemorrhagic in ethnobotanical records is consistent with the known haemostatic properties of condensed tannin-containing barks used in traditional medicine worldwide. No published wound-healing or haemostatic studies involving Cercocarpus species were identified.
Evidence strength: Traditional use supported by plausible mechanism; no experimental or clinical data identified.
Cardiovascular Effects
Animal studies have indicated potential benefits for cardiovascular health and immune response. This claim, sourced from a non-academic website, could not be verified in peer-reviewed literature. No animal or clinical studies examining cardiovascular parameters following Cercocarpus administration were identified in indexed databases.
Evidence strength: Traditional use as cardiac tonic noted; no verifiable peer-reviewed evidence in any model.
Anti-Inflammatory Activity
The traditional use of Cercocarpus preparations for a range of inflammatory conditions (sores, swellings, respiratory inflammation) is consistent with phytochemical properties expected from bark-rich, polyphenol-containing Rosaceae. Preliminary laboratory studies suggest that extracts from Cercocarpus species may help modulate inflammatory pathways. However, no primary peer-reviewed studies examining cyclooxygenase inhibition, cytokine modulation, or other measurable anti-inflammatory endpoints for Cercocarpus extracts were identified in indexed databases.
Evidence strength: Consistent with traditional use and family chemistry; no peer-reviewed evidence confirmed.
Immune Modulation
Animal studies have indicated potential benefits for cardiovascular health and immune response, though these claims appear in non-peer-reviewed sources and no primary publications were identified. No immunological studies of Cercocarpus extracts are available in indexed scientific literature.
Evidence strength: Not substantiated by available peer-reviewed data.
Body Systems and Health Areas Associated with Mountain Mahogany
Based on the totality of documented traditional use, the body systems and health areas with which mountain mahogany has been associated include:
- Gastrointestinal system: Diarrhea, stomach ache, laxative use, general digestive tonic
- Respiratory system: Colds, coughs, pneumonia, tuberculosis (traditional use only)
- Integumentary system (skin): Wounds, burns, sores, syphilitic lesions, earache (topical preparations)
- Cardiovascular system: Traditional classification as "cardiac" and use for heart troubles
- Haematological/haemostatic system: Antihaemorrhagic bark use, treatment of spitting up blood
- Genitourinary/reproductive system: Treatment of venereal disease (gonorrhea, syphilis)
- General tonic/systemic: Whole-body strengthener and tonic applications noted by multiple tribes
Dosage Forms and Reported Dosages
No formal clinical trials have established therapeutic dosage ranges for mountain mahogany preparations. Accordingly, no evidence-based dosage recommendations can be cited. The following preparations and contexts have been noted in ethnobotanical and botanical reference literature:
- Bark decoction (internal): Bark boiled in water; preparation specifics (quantity, concentration) not recorded in available sources.
- Leaf infusion (internal): Used as a general tonic or strengthener; no quantity specified in reviewed sources.
- Cold infusion of leaves (internal): Used by the Tewa as a laxative. No dosage specified.
- Bark tea with Ephedra: Part of the bark is boiled with Ephedra to give the tea a pleasing taste; Cercocarpus bark tea is also used for treating colds. No dosage specified.
- Powdered wood poultice (topical): Green powdered wood applied to sores, cuts, wounds, and burns. Quantity not specified.
- Charcoal powder (topical): Wood burned, the charcoal powdered, and applied to burns. Quantity not specified.
- Dried plant exudate (topical): An exudation from the plant has been dried, ground into a powder and applied to the ear to treat earaches.
No standardized commercial preparations with published dosage protocols were identified in peer-reviewed or institutional sources. Contemporary dietary supplement products containing mountain mahogany are generally formulated as proprietary blends with undisclosed individual ingredient quantities.
Safety Considerations
General Safety Profile
No known hazards have been formally documented in botanical reference literature for Cercocarpus montanus. The plant has a long history of oral consumption as a tea or decoction by multiple Native American peoples, suggesting a reasonable degree of tolerance at the amounts traditionally consumed. However, the absence of formal toxicological studies means that safety in terms of chronic or high-dose consumption, specific contraindications, or interaction effects cannot be definitively characterized.
Absence of Clinical Toxicological Data
No published human toxicological studies, adverse event reports, or pharmacovigilance data for Cercocarpus preparations were identified in PubMed, PMC, or government safety databases (including the NIH Office of Dietary Supplements and NCCIH databases). While mountain mahogany was employed medicinally by a number of native North American Indian tribes, it is virtually not used in modern herbalism. This near-absence from modern clinical practice means that post-market surveillance data are essentially unavailable.
Animal Toxicity Concerns
Cercocarpus montanus, known as Alder-leaf mountain-mahogany, presents a moderate toxicity danger to canines. When dogs consume any section of alder-leaf mountain-mahogany, they face a poisoning risk due to the plant's inherent toxic properties. The plant exhibits a moderate level of toxicity for felines, with every component of the plant being potentially dangerous. Should a cat consume any portion, it can lead to poisoning. Lacking specific toxic substance identification, it is vital to observe for any unusual conduct or distress in animals. These claims appear in secondary rather than primary toxicological literature, and the specific toxic constituents responsible for animal toxicity have not been formally identified in peer-reviewed studies.
Drug Interactions
No formal drug interaction studies involving Cercocarpus preparations and pharmaceutical drugs have been identified in indexed scientific literature. Given the likely presence of condensed tannins, theoretical interactions with drugs known to bind tannins (including some oral medications where tannins may reduce bioavailability) cannot be excluded but remain unstudied for this genus specifically.
Pregnancy, Lactation, and Pediatric Use
No safety data regarding use during pregnancy, lactation, or in pediatric populations are available from peer-reviewed sources. Ethnobotanical records note that bark decoctions were used to treat diarrhea in children, indicating traditional pediatric use, but no formal safety evaluations exist.
Regulatory Status
Mountain mahogany is not included in any current regulatory monograph from the German Commission E, ESCOP, WHO monographs program, or the European Medicines Agency (EMA) Committee on Herbal Medicinal Products. It is not evaluated in an NIH Office of Dietary Supplements fact sheet. In the United States, it may appear as an ingredient in dietary supplements under the general DSHEA framework, but it has not been evaluated by the FDA for safety or efficacy as a drug.
Current Status in Modern Herbalism and Research
Mountain mahogany was employed medicinally by a number of native North American Indian tribes who used it to treat a variety of complaints. It is virtually not used in modern herbalism. This assessment, consistent across multiple botanical databases, highlights the significant gap between its historical traditional use and its current scientific or clinical development. Despite the paucity of large-scale human studies, the phytochemical profile of mountain mahogany supports its inclusion in nutritional products aimed at promoting general health. The plant's traditional use, coupled with emerging laboratory evidence, provides a promising foundation for its continued investigation. However, more research — particularly well-controlled clinical trials — is needed to fully validate its efficacy and safety in humans.
The genus Cercocarpus represents an understudied area of North American ethnopharmacology. Whereas many Indigenous North American medicinal plants have attracted significant phytochemical and pharmacological investigation over the past several decades, mountain mahogany species have not been subjects of systematic study in peer-reviewed literature. The combination of documented traditional use across a broad range of medical applications, the plant's membership in a chemically rich family (Rosaceae), and its unique nitrogen-fixing biology make it a candidate for future phytochemical characterization and pharmacological investigation.
References
Go back